Advertisement
Commentary| Volume 135, ISSUE 7, P1713-1714, July 2015

A New View of Vitiligo: Looking at Normal-Appearing Skin

  • Mauro Picardo
    Correspondence
    Cutaneous Physiopathology and Integrated Center of Metabolomics Research, San Gallicano Dermatologic Institute, IRCCS, Via Elio Chianesi 53, Rome 00144, Italy
    Affiliations
    Cutaneous Physiopathology and Integrated Center of Metabolomics Research, San Gallicano Dermatologic Institute, IRCCS, Rome, Italy
    Search for articles by this author
  • Emanuela Bastonini
    Affiliations
    Cutaneous Physiopathology and Integrated Center of Metabolomics Research, San Gallicano Dermatologic Institute, IRCCS, Rome, Italy
    Search for articles by this author
      Debate over the pathogenesis of vitiligo is still ongoing among scientists, with several hypotheses currently under consideration. The study by Wagner et al. in this issue focuses on the role of E-cadherin-mediated cell adhesion in vitiliginous epidermis under oxidative and mechanical stress. Their work highlights how alterations in cell–cell adhesion across nonlesional melanocyte membranes in patients with vitiligo argue for primary intrinsic defects in the melanocytes.
      Vitiligo, the most common disorder of depigmentation, is an acquired disease characterized by a progressive loss of melanocytes from the epidermis and follicular reservoir. New definition, assessment, and treatment criteria have been proposed for clinical research in vitiligo (
      • Ezzedine K.
      • Lim H.W.
      • Suzuki T.
      • et al.
      Revised classification/nomenclature of vitiligo and related issues: the Vitiligo Global Issues Consensus Conference.
      ;
      • Eleftheriadou V.
      • Thomas K.
      • van Geel N.
      • et al.
      Developing core outcome set for vitiligo clinical trials: international e-Delphi consensus.
      ).
      Despite recent studies that have contributed new knowledge about the disease, understanding its pathogenesis remains a major challenge. Although several hypotheses have been proposed, an autoimmune response against melanocytes remains the leading candidate. Accordingly, genetic defects in loci encoding immunoregulatory proteins and melanocyte components that mediate the immune targeting of melanocytes have been reported (
      • Jin Y.
      • Birlea S.A.
      • Fain P.R.
      • et al.
      Genome-wide association analyses identify 13 new susceptibility loci for generalized vitiligo.
      ). Nevertheless, recent evidence argues for intrinsic metabolic defects in nonlesional melanocytes, leading to intracellular oxidative stress, as the primary intracellular signal for melanocyte degeneration. Recognizing that living cells are subjected to exogenously or endogenously produced reactive oxygen species, elevated oxidative stress may be the initial event that leads to the activation of the antimelanocyte immune responses in patients with genetic predisposition to autoimmunity (
      • Dell’Anna M.L.
      • Picardo M.
      A review and a new hypothesis for non-immunological pathogenic mechanisms in vitiligo.
      ;
      • Schallreuter K.U.
      • Salem M.A.
      • Gibbons N.C.
      • et al.
      Blunted epidermal L-tryptophan metabolism in vitiligo affects immune response and ROS scavenging by Fenton chemistry, part 2: Epidermal H2O2/ONOO(-)-mediated stress in vitiligo hampers indoleamine 2,3-dioxygenase and aryl hydrocarbon receptor-mediated immune response signaling.
      ;
      • Denat L.
      • Kadekaro A.L.
      • Marrot L.
      • et al.
      Melanocytes as instigators and victims of oxidative stress.
      ;
      • Ezzedine K.
      • Eleftheriadou V.
      • Whitton M.
      • et al.
      Vitiligo.
      ). Consistent with the idea that increased oxidative stress and an impaired ability to manage stress effectively are hallmarks of vitiligo, is the observation that melanocytes from nonlesional skin show alterations of pathways leading to a stress-induced premature senescence-like phenotype (
      • Bellei B.
      • Pitisci A.
      • Ottaviani M.
      • et al.
      Vitiligo: a possible model of degenerative diseases.
      ).
      Nevertheless, the mechanisms of melanocyte disappearance remain uncertain.
      • Harris J.E.
      • Harris T.H.
      • Weninger W.
      • et al.
      A mouse model of vitiligo with focused epidermal depigmentation requires IFN-γ for autoreactive CD8+T-cell accumulation in the skin.
      demonstrated that depigmentation is accompanied by an accumulation of autoreactive CD8+ cells and local INF-γ production in the skin, supporting an autoimmune hypothesis. Still, plasmacytoid dendritic cells, which are part of the perilesional cellular infiltrate and the major IFN-α-producing cell subset, may sustain the recruitment and activation of T cells (
      • Bertolotti A.
      • Boniface K.
      • Vergier B.
      • et al.
      Type I interferon signature in the initiation of the immune response in vitiligo.
      ). In support of this mechanism, apoptosis in vitiligo melanocytes has also been demonstrated (
      • Wu J.
      • Zhou M.
      • Wan Y.
      • et al.
      CD8+T cells from vitiligo perilesional margins induce autologous melanocyte apoptosis.
      ).
      The paper by
      • Wagner R.Y.
      • Luciani F.
      • Cario-Andre M.
      • et al.
      Altered E-cadherin levels and distribution in melanocytes precedes manifestations of vitiligo.
      ) provides new insight into the loss of melanocytes by demonstrating altered cell–cell adhesion that, in turn, is linked to the absence and discontinuous distributions of E-cadherin in normal-appearing skin. E-cadherin is one member of a family of Ca2+-dependent transmembrane proteins, and it mediates melanocyte–keratinocyte interactions in the epidermis. In vitiligo, its loss from the membrane specifically affects melanocytes, because usual levels are much lower than in keratinocytes. Moreover, B-catenin, the partner of E-cadherin in regulating cell–cell adhesion, is similarly absent or discontinuously distributed in melanocyte membranes from nonlesional skin of patients with vitiligo. Melanocyte distribution in the basal layer of nonlesional skin is altered. Although the total number of melanocytes is similar to that of controls, in vitiligo more melanocytes are detached from the basal membrane and located in a suprabasal location where they seem to be more susceptible to apoptosis. Interestingly, IL-1β expression is similar to that of control skin, suggesting that alterations in cellular adhesion cannot be attributed to previous activation of an inflammatory process.
      These data are in agreement with the melanocytorrhagy hypothesis that has been proposed as the primary event in melanocytic detachment following a mechanical trauma (
      • Gauthier Y.
      • Cario-Andre M.
      • Lepreux S.
      • et al.
      Melanocyte detachment after skin friction in non lesional skin of patients with generalized vitiligo.
      ) and with the reduced number of melanocytes in the basal layer of reconstructed skin using melanocytes from subjects without vitiligo (
      • Cario-André M.
      • Pain C.
      • Gauthier Y.
      • et al.
      The melanocytorrhagic hypothesis of vitiligo tested on pigmented, stressed, reconstructed epidermis.
      ).
      However, in mice with E-cadherin-deficient melanocytes, depigmentation occurs only after mechanical stress that is caused by repeated brushing of tail skin and in a model of reconstructed epidermis with normal melanocytes after exposure to H2O2 that leads to E-cadherin destabilization. In skin biopsies from patients with vitiligo, E-cadherin alterations are associated with lipoperoxidative damage. Therefore, persistent and widespread stress affecting the distribution of E-cadherin across melanocyte membranes in patients with vitiligo, before the appearance of clinical lesions, cause functional impairment, arguing for primary defects in the melanocytes. In vivo confocal microscopy in nonlesional skin of patients with vitiligo have shown abnormal distribution patterns of brightness at the dermoepidermal junction, suggesting that changes in light reflectance indexes correlate with incomplete distributions of pigment at the basal cell level (
      • Ardigo M.
      • Malizewsky I.
      • Dell’Anna M.L.
      • et al.
      Preliminary evaluation of vitiligo using in vivo reflectance confocal microscopy.
      ).
      Dissociation of melanocytes from the basal membrane may be regulated by growth factors and cytokines released by epidermal and dermal cells. In melanoma cells, hepatocyte growth factor and ET-1 downmodulate E-cadherin expression, allowing melanocytes to dissociate from keratinocytes and to migrate through intercellular spaces (
      • Haass N.K.
      • Herlyn M.
      Normal human melanocyte homeostasis as a paradigm for understanding melanoma.
      ). Recently, immunohistochemical examination of E-cadherin in tissue samples collected from patients with vitiligo, after punch grafting, revealed that melanocytes from normally pigmented donor sites may migrate toward lesional skin and repopulate the depigmented areas because of decreased E-cadherin expression (
      • Kovacs D.
      • Abdel-Raouf H.
      • Al-Khayyat M.
      • et al.
      Vitiligo: characterization of melanocytes in repigmented skin after punch grafting.
      ). The mechanisms that underly the activation of melanocytes after punch grafting have not been fully explained. Nevertheless, the process might be regulated by epidermal and dermal cells that should be able to manage cell adhesion actively.
      Therapeutic options for vitiligo are still limited. Although some mechanisms underlying the interplay between oxidative stress and immunity have been postulated (
      • Richmond J.M.
      • Frisoli M.L.
      • Harris J.E.
      Innate immune mechanisms in vitiligo: danger from within.
      ), understanding mechanisms that cause oxidative stress could provide valuable information to identify new therapeutic targets. The challenge will be to maintain cells metabolically active as requirement for sustaining the energy demand and coping with oxidative stress. Moreover, the analysis has to be extended to pigmented skin to both identify early events in “silent” vitiligo melanocytes and prevent the spread of the disease.

      REFERENCES

        • Ardigo M.
        • Malizewsky I.
        • Dell’Anna M.L.
        • et al.
        Preliminary evaluation of vitiligo using in vivo reflectance confocal microscopy.
        J Eur Acad Dermatol Venereol. 2007; 21: 1344-1350
        • Bellei B.
        • Pitisci A.
        • Ottaviani M.
        • et al.
        Vitiligo: a possible model of degenerative diseases.
        PLoS One. 2013; 8: e59782
        • Bertolotti A.
        • Boniface K.
        • Vergier B.
        • et al.
        Type I interferon signature in the initiation of the immune response in vitiligo.
        Pigment Cell Melanoma Res. 2014; 27: 398-407
        • Cario-André M.
        • Pain C.
        • Gauthier Y.
        • et al.
        The melanocytorrhagic hypothesis of vitiligo tested on pigmented, stressed, reconstructed epidermis.
        Pigment Cell Res. 2007; 20: 385-393
        • Dell’Anna M.L.
        • Picardo M.
        A review and a new hypothesis for non-immunological pathogenic mechanisms in vitiligo.
        Pigment Cell Res. 2006; 19: 406-411
        • Denat L.
        • Kadekaro A.L.
        • Marrot L.
        • et al.
        Melanocytes as instigators and victims of oxidative stress.
        J Invest Dermatol. 2014; 134: 1512-1518
        • Eleftheriadou V.
        • Thomas K.
        • van Geel N.
        • et al.
        Developing core outcome set for vitiligo clinical trials: international e-Delphi consensus.
        Pigment Cell Melanoma Res. 2015;
        • Ezzedine K.
        • Eleftheriadou V.
        • Whitton M.
        • et al.
        Vitiligo.
        Lancet. 2015;
        • Ezzedine K.
        • Lim H.W.
        • Suzuki T.
        • et al.
        Revised classification/nomenclature of vitiligo and related issues: the Vitiligo Global Issues Consensus Conference.
        Pigment Cell Melanoma Res. 2012; 25: E1-13
        • Gauthier Y.
        • Cario-Andre M.
        • Lepreux S.
        • et al.
        Melanocyte detachment after skin friction in non lesional skin of patients with generalized vitiligo.
        Br J Dermatol. 2003; 148: 95-101
        • Haass N.K.
        • Herlyn M.
        Normal human melanocyte homeostasis as a paradigm for understanding melanoma.
        J Invest Dermatol Symp Proc. 2005; 10: 153-163
        • Harris J.E.
        • Harris T.H.
        • Weninger W.
        • et al.
        A mouse model of vitiligo with focused epidermal depigmentation requires IFN-γ for autoreactive CD8+T-cell accumulation in the skin.
        J Invest Dermatol. 2012; 132: 1869-1876
        • Jin Y.
        • Birlea S.A.
        • Fain P.R.
        • et al.
        Genome-wide association analyses identify 13 new susceptibility loci for generalized vitiligo.
        Nat Genet. 2012; 44: 676-680
        • Kovacs D.
        • Abdel-Raouf H.
        • Al-Khayyat M.
        • et al.
        Vitiligo: characterization of melanocytes in repigmented skin after punch grafting.
        J Eur Acad Dermatol Venereol. 2015; 29: 581-590
        • Richmond J.M.
        • Frisoli M.L.
        • Harris J.E.
        Innate immune mechanisms in vitiligo: danger from within.
        Curr Opin Immunol. 2013; 25: 676-682
        • Schallreuter K.U.
        • Salem M.A.
        • Gibbons N.C.
        • et al.
        Blunted epidermal L-tryptophan metabolism in vitiligo affects immune response and ROS scavenging by Fenton chemistry, part 2: Epidermal H2O2/ONOO(-)-mediated stress in vitiligo hampers indoleamine 2,3-dioxygenase and aryl hydrocarbon receptor-mediated immune response signaling.
        FASEB J. 2012; 26: 2471-2485
        • Wagner R.Y.
        • Luciani F.
        • Cario-Andre M.
        • et al.
        Altered E-cadherin levels and distribution in melanocytes precedes manifestations of vitiligo.
        J Invest Dermatol. 2015; 135: 1810-1820
        • Wu J.
        • Zhou M.
        • Wan Y.
        • et al.
        CD8+T cells from vitiligo perilesional margins induce autologous melanocyte apoptosis.
        Mol Med Rep. 2013; 7: 237-241